Evolus, Inc. EOLS
Updated: 10 Aug 2026
No signal published yet
We already track Evolus and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Evolus, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Evolus free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
On August 5, 2026, Evolus reported its second quarter 2026 financial results with global net revenue reaching $84.1 million, a 21% increase year-over-year. The company achieved its third consecutive quarter of positive adjusted EBITDA at $4.7 million and raised its full-year 2026 revenue guidance to between $330 million and $337 million. Evolus also announced an exclusive U.S. licensing agreement for the skin quality product Profhilo.
What Firelda Watch includes for Evolus, Inc.
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Evolus, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Evolus free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more